16 articles
Thirteen new clinical drug candidates targeting diseases such as cancer and obesity were disclosed at the American Chemical Society Fall 2026 meeting, highlighting efforts from major pharmaceutical co
Pfizer announced discontinuation of a topical acne drug candidate presented at the ACS Fall 2026 meeting, halting development originally linked to fatty liver disease research.
Pfizer reported better-than-expected Q2 earnings driven by Eliquis sales and announced $2.5 billion in cost cuts through 2029. The company aims to offset declining COVID revenue while expanding into t
Global markets stabilize during U.S. earnings season, highlighting SpaceX results and oil price fluctuations amid Gulf tensions. Key data includes JOLTS job openings and earnings from pharmaceutical f
Pfizer suspended Premarin vaginal cream sales in India due to supply challenges, impacting millions of women needing estrogen therapy. The product accounted for 37% of India's conjugated estrogen mark
Polish air traffic controller PANSA faces an 80% income drop after Eurocontrol seized fees to enforce a Belgian court ruling on Pfizer's COVID-19 vaccine contracts. The government promises aid while l
A federal judge dismissed Pfizer from a multi-state antitrust lawsuit alleging generic drug price-fixing involving its former Greenstone unit, citing insufficient evidence of conspiracy between 2010 a
Pfizer executives assert China leads Europe in drug innovation, noting 40% of global oncology trials occur there and more innovative medicines launched in 2024. European stakeholders are now debating
Pfizer CFO Dave Denton steps down August 15 for consumer goods, replaced by interim CFO Cecile Guegan. The company seeks a permanent successor following Denton's tenure overseeing major acquisitions,
German Health Minister Nina Warken confirmed drugmakers will not be exempt from new cost-cutting legislation aimed at capping health insurance expenses. Consequently, major firms like Eli Lilly and Pf
Pfizer is reviewing planned investments in Germany following CEO warnings that government drug price cuts threaten long-term predictability. This mirrors similar investment halts by Eli Lilly and Boeh
Eli Lilly solidified its obesity drug market leadership after presenting superior trial data at the American Diabetes Association meeting. Competitors like Roche and Pfizer unveiled new candidates, th
Pfizer forecasts post-2028 growth driven by new obesity and cancer drugs, beating Q1 revenue expectations despite declining COVID vaccine sales. Patent extensions for Vyndamax and a favorable EU court
Escalating U.S.-Iran tensions disrupt shipping in the Strait of Hormuz, driving oil prices above $100 and raising inflation concerns across Asia. Meanwhile, central bankers and major firms like Pfizer
The US FDA approved Pfizer and Arvinas' breast cancer drug Veppanu for patients with ESR1-mutated advanced disease. Clinical trials demonstrated improved survival over standard therapy, accompanied by
Several UK law firms are assessing legal claims against Pfizer alleging the contraceptive Depo-Provera causes meningiomas. Parallel litigation exists in the US, while Pfizer defends the drug's establi
ChemBrief